
Turning Point Therapeutics TPTX
Quartalsbericht 2022-Q2
hinzugefügt 08.08.2022
Turning Point Therapeutics Gesamtverbindlichkeiten 2011-2026 | TPTX
Gesamtverbindlichkeiten Jährlich Turning Point Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 26.8 M | 17.9 M | 5.77 M | 70.8 M | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 70.8 M | 5.77 M | 30.3 M |
Gesamtverbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
4.35 M | $ 0.82 | 1.9 % | $ 4.47 M | ||
|
Aquestive Therapeutics
AQST
|
162 M | $ 4.18 | 2.32 % | $ 363 M | ||
|
MorphoSys AG
MOR
|
1.98 B | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
13.8 M | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
5.38 M | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
109 M | - | - | $ 86.2 M | ||
|
AgeX Therapeutics
AGE
|
6.61 M | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
62.5 M | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
7.27 M | - | 1.93 % | $ 17.4 M | ||
|
argenx SE
ARGX
|
704 M | $ 832.14 | -0.97 % | $ 25 B | ||
|
I-Mab
IMAB
|
707 M | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.45 B | - | - | $ 40.3 B | ||
|
Akero Therapeutics
AKRO
|
75.8 M | - | - | $ 3.67 B | ||
|
Ascendis Pharma A/S
ASND
|
1.47 B | $ 232.76 | -0.95 % | $ 5 B | ||
|
Biophytis SA
BPTS
|
20.4 M | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
126 M | - | -0.23 % | $ 916 M | ||
|
Allena Pharmaceuticals
ALNA
|
15.9 M | - | 3.16 % | $ 1.9 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
8.16 M | - | -1.52 % | $ 24.7 M | ||
|
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | ||
|
Midatech Pharma plc
MTP
|
6.46 M | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
5.89 M | $ 3.34 | 0.27 % | $ 8.04 B | ||
|
Akouos
AKUS
|
45.1 M | - | 0.23 % | $ 488 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
46.6 M | - | - | $ 10.1 M | ||
|
Acorda Therapeutics
ACOR
|
395 M | - | -24.86 % | $ 820 K | ||
|
Atea Pharmaceuticals
AVIR
|
25.8 M | $ 4.59 | -1.4 % | $ 387 M | ||
|
Acer Therapeutics
ACER
|
28.4 M | - | 2.71 % | $ 14 M | ||
|
Aravive
ARAV
|
51.5 M | - | -13.39 % | $ 1.45 M | ||
|
Институт стволовых клеток человека
ISKJ
|
1.1 B | - | - | - | ||
|
Applied Genetic Technologies Corporation
AGTC
|
37.2 M | - | - | $ 26.5 M | ||
|
Avenue Therapeutics
ATXI
|
816 K | - | -52.27 % | $ 4.45 M | ||
|
Axsome Therapeutics
AXSM
|
602 M | $ 165.2 | -2.79 % | $ 8.22 B | ||
|
Ayala Pharmaceuticals
AYLA
|
7.43 M | - | - | $ 7.46 M | ||
|
Atreca
BCEL
|
76.6 M | - | -11.76 % | $ 5.79 M | ||
|
Alpine Immune Sciences
ALPN
|
107 M | - | - | $ 2.17 B | ||
|
BioDelivery Sciences International
BDSI
|
137 M | - | -4.8 % | $ 255 M | ||
|
BioVie
BIVI
|
2.55 M | $ 1.25 | 0.1 % | $ 1.85 M | ||
|
Aeterna Zentaris
AEZS
|
21.9 M | - | 5.93 % | $ 314 M | ||
|
BeiGene, Ltd.
BGNE
|
2.59 B | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
11.2 B | $ 190.58 | -2.33 % | $ 27.9 B | ||
|
BioMarin Pharmaceutical
BMRN
|
1.33 B | $ 61.56 | -1.7 % | $ 11.7 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
3.77 M | - | -9.72 % | $ 5.89 M | ||
|
Baudax Bio
BXRX
|
34.3 M | - | 0.59 % | $ 63 K | ||
|
Aptose Biosciences
APTO
|
14.7 M | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
28.4 M | - | -39.0 % | $ 4.57 M | ||
|
Aridis Pharmaceuticals
ARDS
|
38.9 M | - | 17.91 % | $ 11.1 M | ||
|
BioNTech SE
BNTX
|
3.12 B | $ 111.01 | 0.11 % | $ 27.2 B | ||
|
Amneal Pharmaceuticals
AMRX
|
3.32 B | $ 14.68 | 0.1 % | $ 4.54 B | ||
|
Capricor Therapeutics
CAPR
|
36.1 M | $ 28.39 | 1.72 % | $ 760 M | ||
|
CASI Pharmaceuticals
CASI
|
30.3 M | $ 0.35 | -55.89 % | $ 47.6 M |